These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17878741)

  • 1. Perinatal changes of plasma resistin concentrations in pregnancies with normal and restricted fetal growth.
    Briana DD; Boutsikou M; Baka S; Gourgiotis D; Marmarinos A; Hassiakos D; Malamitsi-Puchner A
    Neonatology; 2008; 93(3):153-7. PubMed ID: 17878741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omentin-1 and vaspin are present in the fetus and neonate, and perinatal concentrations are similar in normal and growth-restricted pregnancies.
    Briana DD; Boutsikou M; Baka S; Gourgiotis D; Marmarinos A; Liosi S; Hassiakos D; Malamitsi-Puchner A
    Metabolism; 2011 Apr; 60(4):486-90. PubMed ID: 20488498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating osteoprotegerin and sRANKL concentrations in the perinatal period at term. The impact of intrauterine growth restriction.
    Briana DD; Boutsikou M; Baka S; Hassiakos D; Gourgiotis D; Malamitsi-Puchner A
    Neonatology; 2009; 96(2):132-6. PubMed ID: 19365143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrauterine growth restriction and circulating neurotrophin levels at term.
    Malamitsi-Puchner A; Nikolaou KE; Economou E; Boutsikou M; Boutsikou T; Kyriakakou M; Puchner KP; Hassiakos D
    Early Hum Dev; 2007 Jul; 83(7):465-9. PubMed ID: 17071024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perinatal bone turnover in term pregnancies: the influence of intrauterine growth restriction.
    Briana DD; Gourgiotis D; Boutsikou M; Baka S; Hassiakos D; Vraila VM; Creatsas G; Malamitsi-Puchner A
    Bone; 2008 Feb; 42(2):307-13. PubMed ID: 18024242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of novel adipocytokines with bone biomarkers in intra uterine growth-restricted fetuses/neonates at term.
    Briana DD; Boutsikou M; Boutsikou T; Malamitsi-Puchner A
    J Matern Fetal Neonatal Med; 2014 Jul; 27(10):984-8. PubMed ID: 24106768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum fetuin-A/alpha2-HS-glycoprotein in human pregnancies with normal and restricted fetal growth.
    Briana DD; Boutsikou M; Gourgiotis D; Boutsikou T; Baka S; Marmarinos A; Hassiakos D; Malamitsi-Puchner A
    J Matern Fetal Neonatal Med; 2008 Nov; 21(11):826-30. PubMed ID: 19031279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble fas antigen and soluble fas ligand in intrauterine growth restriction.
    Briana DD; Baka S; Boutsikou M; Liosi S; Vraila VM; Gourgiotis D; Hassiakos D; Malamitsi-Puchner A
    Neonatology; 2010; 97(1):31-5. PubMed ID: 19590243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble vascular endothelial growth factor receptor-1 in intrauterine growth restricted fetuses and neonates.
    Boutsikou T; Malamitsi-Puchner A; Economou E; Boutsikou M; Puchner KP; Hassiakos D
    Early Hum Dev; 2006 Apr; 82(4):235-9. PubMed ID: 16337100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrauterine growth restriction may not suppress bone formation at term, as indicated by circulating concentrations of undercarboxylated osteocalcin and Dickkopf-1.
    Briana DD; Gourgiotis D; Georgiadis A; Boutsikou M; Baka S; Marmarinos A; Hassiakos D; Malamitsi-Puchner A
    Metabolism; 2012 Mar; 61(3):335-40. PubMed ID: 21944272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum cystatin C in pregnancies with normal and restricted fetal growth.
    Malamitsi-Puchner A; Briana DD; Kontara L; Boutsikou M; Baka S; Hassiakos D; Marmarinos A; Gourgiotis D
    Reprod Sci; 2007 Jan; 14(1):37-42. PubMed ID: 17636214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor (IGF)-I and insulin in normal and growth-restricted mother/infant pairs.
    Malamitsi-Puchner A; Briana DD; Gourgiotis D; Boutsikou M; Puchner KP; Baka S; Marmarinos A; Hassiakos D
    Mediators Inflamm; 2007; 2007():42646. PubMed ID: 17497031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Beta-2-microglobulin levels in intrauterine growth-restricted and normal pregnancies.
    Kontara L; Briana DD; Baka S; Boutsikou M; Marmarinos A; Gourgiotis D; Malamitsi-Puchner A
    Fetal Diagn Ther; 2008; 24(3):220-4. PubMed ID: 18753761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cord blood irisin at the extremes of fetal growth.
    Baka S; Malamitsi-Puchner A; Boutsikou T; Boutsikou M; Marmarinos A; Hassiakos D; Gourgiotis D; Briana DD
    Metabolism; 2015 Nov; 64(11):1515-20. PubMed ID: 26307660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perinatal changes of circulating N-terminal pro B-type natriuretic peptide (NT-proBNP) in normal and intrauterine-growth-restricted pregnancies.
    Iacovidou N; Briana DD; Boutsikou M; Gourgiotis D; Baka S; Vraila VM; Hassiakos D; Malamitsi-Puchner A
    Hypertens Pregnancy; 2007; 26(4):463-71. PubMed ID: 18066964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma copeptin may not be a sensitive marker of perinatal stress in healthy full-term growth-restricted fetuses.
    Briana DD; Boutsikou M; Boutsikou T; Dodopoulos T; Gourgiotis D; Malamitsi-Puchner A
    J Matern Fetal Neonatal Med; 2017 Mar; 30(6):705-709. PubMed ID: 27125294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perinatal collagen turnover markers in intrauterine growth restriction.
    Gourgiotis D; Briana DD; Georgiadis A; Boutsikou M; Baka S; Marmarinos A; Hassiakos D; Malamitsi-Puchner A
    J Matern Fetal Neonatal Med; 2012 Sep; 25(9):1719-22. PubMed ID: 22339296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implication of the myokine irisin in maternal energy homeostasis in pregnancies with abnormal fetal growth.
    Briana DD; Boutsikou M; Athanasopoulos N; Marmarinos A; Gourgiotis D; Malamitsi-Puchner A
    J Matern Fetal Neonatal Med; 2016 Nov; 29(21):3429-33. PubMed ID: 26735968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin and adiponectin concentrations in intrauterine growth restricted and appropriate for gestational age fetuses, neonates, and their mothers.
    Kyriakakou M; Malamitsi-Puchner A; Militsi H; Boutsikou T; Margeli A; Hassiakos D; Kanaka-Gantenbein C; Papassotiriou I; Mastorakos G
    Eur J Endocrinol; 2008 Mar; 158(3):343-8. PubMed ID: 18299467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of intrauterine growth restriction on circulating surfactant protein D concentrations in the perinatal period.
    Briana DD; Gourgiotis D; Baka S; Boutsikou M; Vraila VM; Boutsikou T; Hassiakos D; Malamitsi-Puchner A
    Reprod Sci; 2010 Jul; 17(7):653-8. PubMed ID: 20360592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.